These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6126229)

  • 1. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
    Arató M; Bagdy G; Perényi A
    Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
    Lipcsey A
    Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics.
    Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z
    Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia].
    Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG
    Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia.
    Markianos M; Rinieris P; Hatzimanolis J; Stefanis C
    Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 11. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacological approach to the diagnosis of paranoid schizophrenia.
    Masiak M; Marmurowska-Michalowska H; Nagay J; Olajossy M; Perzyński J; Rzecka M; Wielosz M
    Mater Med Pol; 1989; 21(3):228-30. PubMed ID: 2491275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Serum dopamine beta hydroxylase activities in the insulin test].
    Okada F; Yamashita I; Suwa N; Kunita H; Hata S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):643. PubMed ID: 4476636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on dopamine beta hydroxylase in serum].
    Markianos E; Nyström I
    Arzneimittelforschung; 1974 Jul; 24(7):1021-3. PubMed ID: 4603858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.